Home/Filings/4/0001125345-18-000030
4//SEC Filing

Cilinski Lynn 4

Accession 0001125345-18-000030

CIK 0001125345other

Filed

Feb 28, 7:00 PM ET

Accepted

Mar 1, 5:24 PM ET

Size

15.2 KB

Accession

0001125345-18-000030

Insider Transaction Report

Form 4
Period: 2018-02-28
Cilinski Lynn
V P, Controller and Treasurer
Transactions
  • Exercise/Conversion

    Common Stock

    2018-02-28$0.94/sh+7,989$7,5109,912 total
  • Sale

    Common Stock

    2018-02-28$25.01/sh23,967$599,4361,923 total
  • Exercise/Conversion

    Common Stock

    2018-02-28$0.94/sh+7,989$7,51017,901 total
  • Exercise/Conversion

    Employee stock option (right to buy)

    2018-02-287,9890 total
    Exercise: $0.94From: 2012-09-14Exp: 2022-03-13Common Stock (7,989 underlying)
  • Exercise/Conversion

    Common Stock

    2018-02-28$1.51/sh+7,989$12,06325,890 total
  • Exercise/Conversion

    Employee stock option (right to buy)

    2018-02-287,9890 total
    Exercise: $0.94From: 2011-07-09Exp: 2021-01-08Common Stock (7,989 underlying)
  • Exercise/Conversion

    Employee stock option (right to buy)

    2018-02-287,9890 total
    Exercise: $1.51From: 2013-07-06Exp: 2023-01-05Common Stock (7,989 underlying)
Footnotes (2)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 26, 2017.
  • [F2]This transaction was executed in multiple trades at prices ranging from $25.00 to $25.14. The price reported above reflects the weighted average sale price on the date indicated. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

Issuer

MACROGENICS INC

CIK 0001125345

Entity typeother

Related Parties

1
  • filerCIK 0001587150

Filing Metadata

Form type
4
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 5:24 PM ET
Size
15.2 KB